Early-onset IBD describes inflammatory bowel disease diagnosed in children and teens. In this young population, symptoms can affect growth, school performance, and daily life, making timely recognition important. Common signs include persistent abdominal pain, frequent or urgent diarrhea, blood in the stool, weight loss, and fatigue. Because these symptoms can overlap with other conditions, it is essential to see a pediatric gastroenterologist if they persist for more than a few weeks. Early-onset IBD can be Crohn’s disease or ulcerative colitis, and correctly identifying the subtype guides treatment and monitoring. A comprehensive care approach also includes regular growth checks, nutrition assessments, and attention to mental well-being. Diagnosis for early-onset IBD typically starts with a careful history and physical exam, followed by noninvasive tests such as blood work and stool studies, including fecal calprotectin. Imaging like MR enterography or ultrasound helps assess the small intestine, while endoscopy with biopsies provides a definitive diagnosis and distinguishes Crohn’s disease from ulcerative colitis. In some cases, clinicians may observe the response to therapy over a short period to inform the diagnosis. Early and accurate diagnosis lowers the risk of complications like growth delay and intestinal damage, and sets the stage for effective, individualized management. Treatment and management for early-onset IBD are personalized and often multimodal. Depending on disease severity and location, doctors may use anti-inflammatory medications, immunomodulators, or biologics to control inflammation, alongside nutrition strategies that support growth and healing. Nutritional therapy—such as targeted enteral nutrition in certain cases—often plays a central role. Regular follow-up is essential to monitor growth, bone health, and nutrition, and to adjust therapies as the disease evolves. Family education, school coordination, and psychosocial support are important to help your child navigate daily life and development. Beyond traditional care, digital tools aimed at gut health can complement a child’s management of early-onset IBD. InnerBuddies offers a white-label Gut Health Operating System that powers gut microbiome testing products for companies and consumers, bringing advanced microbiome insights into real-world care. Key features include a Gut Microbiome Health Index (0–100) based on an exclusive collaboration with EAFIT University in Colombia, a top 40 bacteria panel with healthy-cohort comparisons, and categorized bacterial functions labeled as positive or negative to track alongside healthy norms. The platform also provides Target Group analysis for focused insights, personalized nutrition advice derived from three-day food diaries and stool data, and tailored probiotic and prebiotic recommendations. You can explore microbiome testing options at the InnerBuddies product page, subscription plans at the InnerBuddies subscription page, or partner opportunities at the InnerBuddies B2B page: InnerBuddies microbiome test, InnerBuddies gut health membership, InnerBuddies become a partner. If you’re considering microbiome-informed options as part of your child’s care, talking with your clinician about how these tools might fit into a comprehensive plan can be a helpful step.